Startups
A startup biotechnology platform company currently focused on precision oncology. EMPIRI is revolutionizing the way we treat cancer by providing empirical, personalized drug response data before treatments are selected for each patient by oncologists. We are building LDTs for specific cancer indications and a first-in-class automated cancer diagnostic instrument to scale our assays. We are also a 10x Genomic Certified Service Provider for single-cell analysis for clinical and preclinical studies.
Overview
Location
United States, Texas, Houston
Employees
1-10
Founded date
2018
FAQ about EMPIRI
When was EMPIRI founded?
EMPIRI was founded in 2018.
Is EMPIRI still active?
Yes, EMPIRI is active; its latest activity on Parsers VC dates from Jul 10, 2026.